We have both prevention and symptomatic trials. Our current prevention trial is listed at the top, followed by our symptomatic trials.
Are you having memory problems or trouble thinking clearly? Have you been diagnosed with Mild Cognitive Impairment (MCI) or mild dementia due to Alzheimer’s disease (early AD)? Are you interested in participating in a clinical trial to help better understand how to slow the progression of Alzheimer’s disease and to evaluate an investigational treatment for individuals with early AD?
This research study (also known as a clinical trial) is of an investigational drug called gantenerumab. If you have Alzheimer’s disease (AD) or may have early symptoms of AD, you may be eligible for this study. AD is a slow progressive disease of the brain that affects memory and other normal brain functions. The brains of individuals with AD have an abundance of plaques and tangles. Plaques are deposits of a protein called amyloid; tangles are twisted fibers of another protein called tau.